Cargando…
Comment on: Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study: reply
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449802/ https://www.ncbi.nlm.nih.gov/pubmed/32594147 http://dx.doi.org/10.1093/rheumatology/keaa255 |
Sumario: |
---|